February 2024
1. NEDOVIC VUKOVIC M, Jaksic M, Smolovic B, Lukic M, et al
   Trends in gastric cancer mortality in Montenegro, 1990 - 2018: joinpoint regression.
   Oncology. 2024 Feb 19. doi: 10.1159/000537739.
   

   >> Share

   
   
2. UNAL OU, Akay S, Gul G, Keser M, et al
   Impact of HER2-Low status in metastatic gastric cancer:A real-world retrospective cohort study.
   Oncology. 2024 Feb 14. doi: 10.1159/000537839.
   

   >> Share

   
   December 2023
3. YAMAMOTO M, Omori T, Shinno N, Hara H, et al
   Prognostic value of a novel index combining the prognostic nutritional index and D-dimer levels for gastric cancer after gastrectomy.
   Oncology. 2023 Dec 30. doi: 10.1159/000533150.
   

   >> Share

   
   October 2023
4. ISHIKAWA A, Yasumatsu R, Fukui T, Kido A, et al
   Kinesin family member B18 is related to gastric mucin phenotype and contributes to gastric cancer progression by regulating epithelial-mesenchymal transition.
   Oncology. 2023 Oct 9. doi: 10.1159/000533791.
   

   >> Share

   
   September 2023
5. CORSO G, Trovato CM, Petitto S, Girardi A, et al
   Clinical implication of CDH1 mutations in genetic testing for diffuse gastric cancer patients.
   Oncology. 2023 Sep 19. doi: 10.1159/000533774.
   

   >> Share

   
   
6. MA J, Da M
   High-mobility group box 1 overexpression predicts a poor prognosis and promotes EMT in gastric cancer by activating TLR4/NF-kappaB signaling.
   Oncology. 2023 Sep 4. doi: 10.1159/000533927.
   

   >> Share

   
   July 2023
7. FUJIMOTO D, Taniguchi K, Takashima J, Kobayashi H, et al
   Postoperative early body weight loss is a risk factor for recurrence in patients with pStage III gastric cancer.
   Oncology. 2023 Jul 26. doi: 10.1159/000532089.
   

   >> Share

   
   June 2023
8. NAKAZAWA N, Sohda M, Katayama A, Ide M, et al
   Infiltration of Gastric Cancer Stroma by Tumor-Infiltrating Lymphocytes Correlates with mTOR Signaling.
   Oncology. 2023 Jun 14. doi: 10.1159/000531475.
   

   >> Share

   
   
9. PECORA I, Ugolini C, Giannini R, Giordano M, et al
   Dynamic profiling of the immune tumor microenvironment in locally advanced gastric cancer treated with perioperative chemotherapy.
   Oncology. 2023 Jun 12. doi: 10.1159/000530853.
   

   >> Share

   
   
10. CHENG R, Peng Y, Sun X, Zhang S, et al
    Circulating tumor cells as diagnostic markers of early gastric cancer and gastric precancerous lesions.
    Oncology. 2023 Jun 1. doi: 10.1159/000531323.
    

    >> Share

    
    May 2023
11. ABEDINI F, Amjadi O, Hedayatizadeh-Omran A, Lira S, et al
    Serotonin Receptors and Acetylcholinesterase Gene Expression Alternations: The Potential Value on Tumor Microenvironment of Gastric Cancer.
    Oncology. 2023 May 3:1. doi: 10.1159/000530878.
    

    >> Share

    
    February 2023
12. ESEN SA, Ozgun YM, Hasturk D, Ucar G, et al
    Neoadjuvant Chemotherapy Followed by Cytoreductive Surgery and HIPEC Improves Survival in Peritoneal Metastatic Gastric Cancer.
    Oncology. 2023 Feb 21. doi: 10.1159/000528609.
    

    >> Share

    
    January 2023
13. HINGORANI M, Goody R, Bozas G, Zahid K, et al
    Neoadjuvant Management of Adenocarcinoma of the Esophagus and Esophagogastric Junction: Review of Randomized Evidence and Definition of Optimum Treatment Algorithm.
    Oncology. 2023;101:553-564.
    

    >> Share

    
    November 2022
14. HAYANO K, Ohira G, Kano M, Suito H, et al
    Prognostic impact of hepatic steatosis evaluated by CT on immunotherapy for gastric cancer; associations with sarcopenia, systemic inflammation, and hormones.
    Oncology. 2022 Nov 15. pii: 000528005. doi: 10.1159/000528005.
    

    >> Share

    
    October 2022
15. OHHARA Y, Kinoshita I, Suzuki A, Imagawa M, et al
    Expression of karyopherin alfa 2 and karyopherin beta 1 correlate with poor prognosis in gastric cancer.
    Oncology. 2022 Oct 21. pii: 000526807. doi: 10.1159/000526807.
    

    >> Share

    
    
16. OJIMA T, Hayata K, Kitadani J, Takeuchi A, et al
    Risk Factors of Postoperative Intra-Abdominal Infectious Complications After Robotic Gastrectomy for Gastric Cancer.
    Oncology. 2022 Oct 21. pii: 000526920. doi: 10.1159/000526920.
    

    >> Share

    
    
17. TANIOKA H, Mori Y, Tanaka T, Yasui K, et al
    Genomically stable gastric cancer characterized by hypomethylation in Wnt signal cascade.
    Oncology. 2022 Oct 14. pii: 000527098. doi: 10.1159/000527098.
    

    >> Share

    
    
18. ARIGAMI T, Matsushita D, Okubo K, Shimonosono M, et al
    Clinical Significance of Eligibility Criteria Determined by the SPIRITS Trial in Patients with Advanced Gastric Cancer.
    Oncology. 2022 Oct 5. pii: 000527114. doi: 10.1159/000527114.
    

    >> Share

    
    September 2022
19. ANDO T, Hosokawa A, Sakumura M, Motoo I, et al
    Factors, including clinical trial eligibility, associated with induction of third-line treatment for advanced gastric cancer.
    Oncology. 2022 Sep 14. pii: 000526577. doi: 10.1159/000526577.
    

    >> Share

    
    
20. NAKAZAWA N, Sohda M, Ide M, Shimoda Y, et al
    PROX1 was associated with LGR5 and Wnt signaling and contributed to poor prognosis in gastric cancer.
    Oncology. 2022 Sep 14. pii: 000526734. doi: 10.1159/000526734.
    

    >> Share

    
    March 2022
21. MIURA S, Wakahara T, Yamauchi S, Yasuhara Y, et al
    The Amount and Concentration of Drain Amylase Together Predict Postoperative Pancreatic Fistula after Gastric Cancer Surgery More Accurately than the Concentration Alone.
    Oncology. 2022 Mar 25. pii: 000524301. doi: 10.1159/000524301.
    

    >> Share

    
    January 2022
22. ALLAW MB, Switchenko JM, Khalil L, Wu C, et al
    Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors.
    Oncology. 2022;100:131-139.
    

    >> Share

    
    
23. ROGERS JE, Wang X, Trail A, Ajani JA, et al
    Beyond Front-Line Therapy for Unresectable Gastroesophageal Adenocarcinoma: Are There Differences in Subsequent Therapy Sequencing?
    Oncology. 2022;100:182-187.
    

    >> Share

    
    August 2021
24. NAKAZAWA N, Sohda M, Ide M, Shimoda Y, et al
    High L-Type Amino Acid Transporter 1 Levels Are Associated with Chemotherapeutic Resistance in Gastric Cancer Patients.
    Oncology. 2021 Aug 13:1-8. doi: 10.1159/000517371.
    

    >> Share

    
    July 2021
25. TOKUMARU S, Koizumi T, Sekino Y, Takeuchi N, et al
    Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment with Nivolumab for Gastric Cancer.
    Oncology. 2021 Jul 19:1-9. doi: 10.1159/000517344.
    

    >> Share

    
    March 2021
26. OKUBO K, Arigami T, Matsushita D, Tanaka T, et al
    Clinical Impact of the Prognostic Nutritional Index as a Predictor of Outcomes in Patients with Stage II/III Gastric Cancer: A Retrospective Cohort Study.
    Oncology. 2021 Mar 5:1-9. doi: 10.1159/000514572.
    

    >> Share

    
    January 2021
27. JIANG DM, Sim HW, Espin-Garcia O, Chan BA, et al
    Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer.
    Oncology. 2021;99:49-56.
    

    >> Share

    
    
28. NAMIKAWA T, Maeda M, Yokota K, Iwabu J, et al
    Enteral Vitamin B12 Supplementation Is Effective for Improving Anemia in Patients Who Underwent Total Gastrectomy.
    Oncology. 2021;99:225-233.
    

    >> Share

    
    
29. ABDELHAKEEM A, Patnana M, Wang X, Rogers JE, et al
    Influence of Baseline Positron Emission Tomography in Metastatic Gastroesophageal Cancer on Survival and Response to Therapy.
    Oncology. 2021;99:659-664.
    

    >> Share

    
    October 2020
30. UBUKATA Y, Ogata K, Sohda M, Yokobori T, et al
    Role of PD-L1 Expression during the Progression of Submucosal Gastric Cancer.
    Oncology. 2020 Oct 28:1-8. doi: 10.1159/000509033.
    

    >> Share

    
    January 2020
31. WUNDSAM HV, Doleschal B, Prommer R, Venhoda C, et al
    Clinical Outcome in Patients with Carcinoma of the Esophagogastric Junction Treated with Neoadjuvant Radiochemotherapy or Perioperative Chemotherapy: A Two-Center Retrospective Analysis.
    Oncology. 2020;98:706-713.
    

    >> Share

    
    
32. ABDELHAKEEM A, Wang X, Rogers JE, Trail A, et al
    Outcomes of Advanced Gastroesophageal Cancer Patients with Equivocal HER2 Expression with or without ERBB2 Gene Amplification.
    Oncology. 2020;98:884-888.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share